TMED · NASDAQ · ETF
T. Rowe Price Health Care ETF (TMED) Price, Holdings & Fees
T. Rowe Price Health Care ETF (TMED) closed at $338.26 on Oct 9, 2026, up 0.32% from the previous close of $337.19.
Share price, past year
1Y +4.64%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $338.26 |
| Sep 30, 2026 | $324.80 |
| Aug 31, 2026 | $336.64 |
| Jul 31, 2026 | $347.01 |
| Jun 30, 2026 | $354.81 |
| May 29, 2026 | $348.25 |
| Apr 30, 2026 | $353.43 |
| Mar 31, 2026 | $359.10 |
| Feb 27, 2026 | $347.20 |
| Jan 30, 2026 | $321.08 |
| Dec 31, 2025 | $315.94 |
| Nov 28, 2025 | $318.15 |
| Oct 31, 2025 | $309.32 |
Key statistics
- Expense ratio
- 0.44%
- as of Feb 28, 2026
- Net assets
- $23M
- as of Jun 30, 2026
- Holdings
- 102
- as of Jun 30, 2026
- 52-week range
- $307.20 – $378.20
T. Rowe Price Health Care ETF's expense ratio is 0.44%: $44.00 a year on $10,000 invested.
Holdings
T. Rowe Price Health Care ETF held 102 investments worth $23.03M as of Jun 30, 2026. Its largest holding was ELI LILLY & CO, at 16.71% of the fund.
| # | Holding | % of fund | Value |
|---|---|---|---|
| 1 | ELI LILLY & CO | 16.71% | $3.85M |
| 2 | UNITEDHEALTH GROUP INC | 6.52% | $1.50M |
| 3 | GILEAD SCIENCES INC | 4.44% | $1.02M |
| 4 | THERMO FISHER SCIENTIFIC INC | 4.11% | $947.57K |
| 5 | DANAHER CORP | 2.96% | $681.92K |
| 6 | CENCORA INC | 2.75% | $633.88K |
| 7 | AGILENT TECHNOLOGIES INC | 2.61% | $601.72K |
| 8 | ALNYLAM PHARMACEUTICALS INC | 2.60% | $597.85K |
| 9 | INTUITIVE SURGICAL INC | 2.43% | $560.73K |
| 10 | INSULET CORP | 2.38% | $548.25K |
| 11 | STRYKER CORP | 2.22% | $511.30K |
| 12 | DYNE THERAPEUTICS INC | 2.03% | $467.94K |
| 13 | ELANCO ANIMAL HEALTH INC | 1.91% | $439.63K |
| 14 | PFIZER INC | 1.91% | $438.93K |
| 15 | CYTOKINETICS INC | 1.69% | $388.81K |
| 16 | WATERS CORP | 1.68% | $387.79K |
| 17 | WEST PHARMACEUTICAL SERVICES | 1.65% | $380.54K |
| 18 | ASCENDIS PHARMA A/S | 1.60% | $368.61K |
| 19 | BIOGEN INC | 1.55% | $357.36K |
| 20 | MCKESSON CORP | 1.46% | $335.49K |
| 21 | DEXCOM INC | 1.46% | $335.13K |
| 22 | IMMUNOME INC | 1.38% | $318.04K |
| 23 | BIONTECH SE-ADR | 1.29% | $296.64K |
| 24 | HUMANA INC | 1.24% | $286.40K |
| 25 | DENALI THERAPEUTICS INC | 1.22% | $281.94K |
Top 25 of 102 holdings, as of Jun 30, 2026. Percentages are of the fund's net assets.
What the fund owns
| Asset type | % of fund |
|---|---|
| Stocks | 99.27% |
| Cash and short-term investments | 0.73% |
| Country | % of fund |
|---|---|
| United States | 93.26% |
| Denmark | 1.60% |
| Germany | 1.59% |
| Cayman Islands | 1.05% |
| Netherlands | 0.87% |
| Switzerland | 0.49% |
| Canada | 0.32% |
| Jersey | 0.31% |
| Italy | 0.30% |
| France | 0.12% |
Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.
Monthly total returns
Over the 3 months to Jun 30, 2026, T. Rowe Price Health Care ETF's total return was +17.90%, as reported to the SEC.
| Month | Total return |
|---|---|
| Jun 30, 2026 | +7.80% |
| May 31, 2026 | +5.54% |
| Apr 30, 2026 | +3.63% |
The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.
Fund profile
- Name
- T. Rowe Price Health Care ETF
- Ticker
- TMED
- Exchange
- NASDAQ
- Fund type
- ETF
- Trust
- T. Rowe Price Exchange-Traded Funds, Inc.
- SEC series ID
- S000092023
- SEC CIK
- 0001795351
- Fractional shares
- No
Recent SEC filings
- Aug 27, 2026
- Aug 24, 2026
Shareholder reports and prospectuses are filed by T. Rowe Price Exchange-Traded Funds, Inc., the trust behind T. Rowe Price Health Care ETF, and cover all of its funds.
Frequently asked questions
What is TMED's price?
T. Rowe Price Health Care ETF (TMED) closed at $338.26 on Oct 9, 2026, up 0.32% from the previous close of $337.19.
What is TMED's expense ratio?
T. Rowe Price Health Care ETF's expense ratio is 0.44%: $44.00 a year on $10,000 invested.
What does TMED hold?
T. Rowe Price Health Care ETF held 102 investments worth $23.03M as of Jun 30, 2026. Its largest holding was ELI LILLY & CO, at 16.71% of the fund. Its five largest holdings were ELI LILLY & CO, UNITEDHEALTH GROUP INC, GILEAD SCIENCES INC, THERMO FISHER SCIENTIFIC INC, DANAHER CORP.
How has TMED performed?
Over the 3 months to Jun 30, 2026, T. Rowe Price Health Care ETF's total return was +17.90%, as reported to the SEC.
Sources and methodology
Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of Jun 30, 2026 (filed Aug 27, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of Feb 28, 2026. Prices are generated sample data for development. Data sources and disclosures